1.Executive Summary |
2.Global Therapeutic Drug Monitoring Market Introduction |
2.1.Global Therapeutic Drug Monitoring Market - Taxonomy |
2.2.Global Therapeutic Drug Monitoring Market - Definitions |
2.2.1. By Drug Type |
2.2.2. By Technology |
2.2.3. By Region |
3.Global Therapeutic Drug Monitoring Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Therapeutic Drug Monitoring Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Therapeutic Drug Monitoring Market By Drug Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Antibiotics (Chloramphenicol, Linezolid, Piperacillin/Tazobactam, Rifampicin, Vancomycin, Gentamicin, Amikacin, Tobramycin, Teicoplanin, Ceftazidime, Meropenem, Nafcillin, Ticarcillin) |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Addiction Therapeutics (Buprenorphine, Methadone, Naltrexone, Tapentadol) |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Analgesic (Paracetamol, Ibuprofen, Naproxen, Aspirin, Tramadol) |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Anticancer Drugs (5-Fluorouracil, Docetaxel, Methotrexate, Paclitaxel, Imatinib, Busulfan) |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Alzheimer Disease (Donepezil, Galantamine, Memantine) |
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Analeptics (Caffeine, Theophylline) |
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Antiarrhythmic Drugs (Amiodarone, Digoxin, Flecainide, Mexiletine, Verapamil, Digitoxin, Lidocaine) |
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
5.8. Anticoagulants (Dabigatran Warfarin) |
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.8.3. Market Opportunity Analysis |
5.9. Antihypertensives (Propranolol) |
5.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.9.3. Market Opportunity Analysis |
5.10. Antidepressants (Citalopram, Fluoxetine, Fluvoxamine, Sertraline, Venlafaxine, Trazodone, Protriptyline, Nortriptyline, Imipramine, Desipramine, Doxepin, Clomipramine, Bupropion, Amitryptiline) |
5.10.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.10.3. Market Opportunity Analysis |
5.11. Antiepileptics (Ethosuximide, Felbamate, Gabapentin, Lamotrigine, Pregabaline, Topiramate, Zonisamide, Carbamazepine, Valproic Acid, Lacosamide, Levetiracetam, Phenobarbital, Phenytoin) |
5.11.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.11.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.11.3. Market Opportunity Analysis |
5.12. Anti-HIV Drugs (Atazanavir, Indinavir, Lopinavir, Nelfinavir, Ritonavir, Saquinavir, Darunavir, Fosamprenavir, Tipranavir, Efavirenz, Etravirine, Nevirapine, Rilpivirine) |
5.12.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.12.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.12.3. Market Opportunity Analysis |
5.13. Antipsychotics (Aripiprazole, Clozapine, Haloperidol, Olanzapine, Ziprasidone, Chlorpromazine, Lithium, Lurasidone, Paliperidone, Perphenazine, Quetiapine, Risperidone, Thiothixene) |
5.13.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.13.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.13.3. Market Opportunity Analysis |
5.14. Hormones (T3, T4, TSH) |
5.14.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.14.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.14.3. Market Opportunity Analysis |
5.15. Immunosuppressants (Cyclosporin A, Everolimus, Mycophenolic acid, Sirolimus, Tacrolimus) |
5.15.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.15.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.15.3. Market Opportunity Analysis |
5.16. Antifungals (Fluconazole, Itraconazole, Voriconazole, Posaconazole, Anidulafungin, Ketoconazole) |
5.16.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.16.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.16.3. Market Opportunity Analysis |
6.Global Therapeutic Drug Monitoring Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Immuno- Assay, |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Mass Spectrometry, |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. GC-MS/MS, |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Others |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7.Global Therapeutic Drug Monitoring Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.North America Therapeutic Drug Monitoring Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Antibiotics (Chloramphenicol, Linezolid, Piperacillin/Tazobactam, Rifampicin, Vancomycin, Gentamicin, Amikacin, Tobramycin, Teicoplanin, Ceftazidime, Meropenem, Nafcillin, Ticarcillin) |
8.1.2.Addiction Therapeutics (Buprenorphine, Methadone, Naltrexone, Tapentadol) |
8.1.3.Analgesic (Paracetamol, Ibuprofen, Naproxen, Aspirin, Tramadol) |
8.1.4.Anticancer Drugs (5-Fluorouracil, Docetaxel, Methotrexate, Paclitaxel, Imatinib, Busulfan) |
8.1.5.Alzheimer Disease (Donepezil, Galantamine, Memantine) |
8.1.6.Analeptics (Caffeine, Theophylline) |
8.1.7.Antiarrhythmic Drugs (Amiodarone, Digoxin, Flecainide, Mexiletine, Verapamil, Digitoxin, Lidocaine) |
8.1.8.Anticoagulants (Dabigatran Warfarin) |
8.1.9.Antihypertensives (Propranolol) |
8.1.10.Antidepressants (Citalopram, Fluoxetine, Fluvoxamine, Sertraline, Venlafaxine, Trazodone, Protriptyline, Nortriptyline, Imipramine, Desipramine, Doxepin, Clomipramine, Bupropion, Amitryptiline) |
8.1.11.Antiepileptics (Ethosuximide, Felbamate, Gabapentin, Lamotrigine, Pregabaline, Topiramate, Zonisamide, Carbamazepine, Valproic Acid, Lacosamide, Levetiracetam, Phenobarbital, Phenytoin) |
8.1.12.Anti-HIV Drugs (Atazanavir, Indinavir, Lopinavir, Nelfinavir, Ritonavir, Saquinavir, Darunavir, Fosamprenavir, Tipranavir, Efavirenz, Etravirine, Nevirapine, Rilpivirine) |
8.1.13.Antipsychotics (Aripiprazole, Clozapine, Haloperidol, Olanzapine, Ziprasidone, Chlorpromazine, Lithium, Lurasidone, Paliperidone, Perphenazine, Quetiapine, Risperidone, Thiothixene) |
8.1.14.Hormones (T3, T4, TSH) |
8.1.15.Immunosuppressants (Cyclosporin A, Everolimus, Mycophenolic acid, Sirolimus, Tacrolimus) |
8.1.16.Antifungals (Fluconazole, Itraconazole, Voriconazole, Posaconazole, Anidulafungin, Ketoconazole) |
8.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Immuno- Assay, |
8.2.2.Mass Spectrometry, |
8.2.3.GC-MS/MS, |
8.2.4.Others |
8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9.Europe Therapeutic Drug Monitoring Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Drug Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Antibiotics (Chloramphenicol, Linezolid, Piperacillin/Tazobactam, Rifampicin, Vancomycin, Gentamicin, Amikacin, Tobramycin, Teicoplanin, Ceftazidime, Meropenem, Nafcillin, Ticarcillin) |
9.1.2.Addiction Therapeutics (Buprenorphine, Methadone, Naltrexone, Tapentadol) |
9.1.3.Analgesic (Paracetamol, Ibuprofen, Naproxen, Aspirin, Tramadol) |
9.1.4.Anticancer Drugs (5-Fluorouracil, Docetaxel, Methotrexate, Paclitaxel, Imatinib, Busulfan) |
9.1.5.Alzheimer Disease (Donepezil, Galantamine, Memantine) |
9.1.6.Analeptics (Caffeine, Theophylline) |
9.1.7.Antiarrhythmic Drugs (Amiodarone, Digoxin, Flecainide, Mexiletine, Verapamil, Digitoxin, Lidocaine) |
9.1.8.Anticoagulants (Dabigatran Warfarin) |
9.1.9.Antihypertensives (Propranolol) |
9.1.10.Antidepressants (Citalopram, Fluoxetine, Fluvoxamine, Sertraline, Venlafaxine, Trazodone, Protriptyline, Nortriptyline, Imipramine, Desipramine, Doxepin, Clomipramine, Bupropion, Amitryptiline) |
9.1.11.Antiepileptics (Ethosuximide, Felbamate, Gabapentin, Lamotrigine, Pregabaline, Topiramate, Zonisamide, Carbamazepine, Valproic Acid, Lacosamide, Levetiracetam, Phenobarbital, Phenytoin) |
9.1.12.Anti-HIV Drugs (Atazanavir, Indinavir, Lopinavir, Nelfinavir, Ritonavir, Saquinavir, Darunavir, Fosamprenavir, Tipranavir, Efavirenz, Etravirine, Nevirapine, Rilpivirine) |
9.1.13.Antipsychotics (Aripiprazole, Clozapine, Haloperidol, Olanzapine, Ziprasidone, Chlorpromazine, Lithium, Lurasidone, Paliperidone, Perphenazine, Quetiapine, Risperidone, Thiothixene) |
9.1.14.Hormones (T3, T4, TSH) |
9.1.15.Immunosuppressants (Cyclosporin A, Everolimus, Mycophenolic acid, Sirolimus, Tacrolimus) |
9.1.16.Antifungals (Fluconazole, Itraconazole, Voriconazole, Posaconazole, Anidulafungin, Ketoconazole) |
9.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Immuno- Assay, |
9.2.2.Mass Spectrometry, |
9.2.3.GC-MS/MS, |
9.2.4.Others |
9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
10.Asia Pacific (APAC) Therapeutic Drug Monitoring Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Drug Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Antibiotics (Chloramphenicol, Linezolid, Piperacillin/Tazobactam, Rifampicin, Vancomycin, Gentamicin, Amikacin, Tobramycin, Teicoplanin, Ceftazidime, Meropenem, Nafcillin, Ticarcillin) |
10.1.2.Addiction Therapeutics (Buprenorphine, Methadone, Naltrexone, Tapentadol) |
10.1.3.Analgesic (Paracetamol, Ibuprofen, Naproxen, Aspirin, Tramadol) |
10.1.4.Anticancer Drugs (5-Fluorouracil, Docetaxel, Methotrexate, Paclitaxel, Imatinib, Busulfan) |
10.1.5.Alzheimer Disease (Donepezil, Galantamine, Memantine) |
10.1.6.Analeptics (Caffeine, Theophylline) |
10.1.7.Antiarrhythmic Drugs (Amiodarone, Digoxin, Flecainide, Mexiletine, Verapamil, Digitoxin, Lidocaine) |
10.1.8.Anticoagulants (Dabigatran Warfarin) |
10.1.9.Antihypertensives (Propranolol) |
10.1.10.Antidepressants (Citalopram, Fluoxetine, Fluvoxamine, Sertraline, Venlafaxine, Trazodone, Protriptyline, Nortriptyline, Imipramine, Desipramine, Doxepin, Clomipramine, Bupropion, Amitryptiline) |
10.1.11.Antiepileptics (Ethosuximide, Felbamate, Gabapentin, Lamotrigine, Pregabaline, Topiramate, Zonisamide, Carbamazepine, Valproic Acid, Lacosamide, Levetiracetam, Phenobarbital, Phenytoin) |
10.1.12.Anti-HIV Drugs (Atazanavir, Indinavir, Lopinavir, Nelfinavir, Ritonavir, Saquinavir, Darunavir, Fosamprenavir, Tipranavir, Efavirenz, Etravirine, Nevirapine, Rilpivirine) |
10.1.13.Antipsychotics (Aripiprazole, Clozapine, Haloperidol, Olanzapine, Ziprasidone, Chlorpromazine, Lithium, Lurasidone, Paliperidone, Perphenazine, Quetiapine, Risperidone, Thiothixene) |
10.1.14.Hormones (T3, T4, TSH) |
10.1.15.Immunosuppressants (Cyclosporin A, Everolimus, Mycophenolic acid, Sirolimus, Tacrolimus) |
10.1.16.Antifungals (Fluconazole, Itraconazole, Voriconazole, Posaconazole, Anidulafungin, Ketoconazole) |
10.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Immuno- Assay, |
10.2.2.Mass Spectrometry, |
10.2.3.GC-MS/MS, |
10.2.4.Others |
10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11.Middle East and Africa (MEA) Therapeutic Drug Monitoring Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Drug Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Antibiotics (Chloramphenicol, Linezolid, Piperacillin/Tazobactam, Rifampicin, Vancomycin, Gentamicin, Amikacin, Tobramycin, Teicoplanin, Ceftazidime, Meropenem, Nafcillin, Ticarcillin) |
11.1.2.Addiction Therapeutics (Buprenorphine, Methadone, Naltrexone, Tapentadol) |
11.1.3.Analgesic (Paracetamol, Ibuprofen, Naproxen, Aspirin, Tramadol) |
11.1.4.Anticancer Drugs (5-Fluorouracil, Docetaxel, Methotrexate, Paclitaxel, Imatinib, Busulfan) |
11.1.5.Alzheimer Disease (Donepezil, Galantamine, Memantine) |
11.1.6.Analeptics (Caffeine, Theophylline) |
11.1.7.Antiarrhythmic Drugs (Amiodarone, Digoxin, Flecainide, Mexiletine, Verapamil, Digitoxin, Lidocaine) |
11.1.8.Anticoagulants (Dabigatran Warfarin) |
11.1.9.Antihypertensives (Propranolol) |
11.1.10.Antidepressants (Citalopram, Fluoxetine, Fluvoxamine, Sertraline, Venlafaxine, Trazodone, Protriptyline, Nortriptyline, Imipramine, Desipramine, Doxepin, Clomipramine, Bupropion, Amitryptiline) |
11.1.11.Antiepileptics (Ethosuximide, Felbamate, Gabapentin, Lamotrigine, Pregabaline, Topiramate, Zonisamide, Carbamazepine, Valproic Acid, Lacosamide, Levetiracetam, Phenobarbital, Phenytoin) |
11.1.12.Anti-HIV Drugs (Atazanavir, Indinavir, Lopinavir, Nelfinavir, Ritonavir, Saquinavir, Darunavir, Fosamprenavir, Tipranavir, Efavirenz, Etravirine, Nevirapine, Rilpivirine) |
11.1.13.Antipsychotics (Aripiprazole, Clozapine, Haloperidol, Olanzapine, Ziprasidone, Chlorpromazine, Lithium, Lurasidone, Paliperidone, Perphenazine, Quetiapine, Risperidone, Thiothixene) |
11.1.14.Hormones (T3, T4, TSH) |
11.1.15.Immunosuppressants (Cyclosporin A, Everolimus, Mycophenolic acid, Sirolimus, Tacrolimus) |
11.1.16.Antifungals (Fluconazole, Itraconazole, Voriconazole, Posaconazole, Anidulafungin, Ketoconazole) |
11.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Immuno- Assay, |
11.2.2.Mass Spectrometry, |
11.2.3.GC-MS/MS, |
11.2.4.Others |
11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12.Latin America Therapeutic Drug Monitoring Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Drug Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Antibiotics (Chloramphenicol, Linezolid, Piperacillin/Tazobactam, Rifampicin, Vancomycin, Gentamicin, Amikacin, Tobramycin, Teicoplanin, Ceftazidime, Meropenem, Nafcillin, Ticarcillin) |
12.1.2.Addiction Therapeutics (Buprenorphine, Methadone, Naltrexone, Tapentadol) |
12.1.3.Analgesic (Paracetamol, Ibuprofen, Naproxen, Aspirin, Tramadol) |
12.1.4.Anticancer Drugs (5-Fluorouracil, Docetaxel, Methotrexate, Paclitaxel, Imatinib, Busulfan) |
12.1.5.Alzheimer Disease (Donepezil, Galantamine, Memantine) |
12.1.6.Analeptics (Caffeine, Theophylline) |
12.1.7.Antiarrhythmic Drugs (Amiodarone, Digoxin, Flecainide, Mexiletine, Verapamil, Digitoxin, Lidocaine) |
12.1.8.Anticoagulants (Dabigatran Warfarin) |
12.1.9.Antihypertensives (Propranolol) |
12.1.10.Antidepressants (Citalopram, Fluoxetine, Fluvoxamine, Sertraline, Venlafaxine, Trazodone, Protriptyline, Nortriptyline, Imipramine, Desipramine, Doxepin, Clomipramine, Bupropion, Amitryptiline) |
12.1.11.Antiepileptics (Ethosuximide, Felbamate, Gabapentin, Lamotrigine, Pregabaline, Topiramate, Zonisamide, Carbamazepine, Valproic Acid, Lacosamide, Levetiracetam, Phenobarbital, Phenytoin) |
12.1.12.Anti-HIV Drugs (Atazanavir, Indinavir, Lopinavir, Nelfinavir, Ritonavir, Saquinavir, Darunavir, Fosamprenavir, Tipranavir, Efavirenz, Etravirine, Nevirapine, Rilpivirine) |
12.1.13.Antipsychotics (Aripiprazole, Clozapine, Haloperidol, Olanzapine, Ziprasidone, Chlorpromazine, Lithium, Lurasidone, Paliperidone, Perphenazine, Quetiapine, Risperidone, Thiothixene) |
12.1.14.Hormones (T3, T4, TSH) |
12.1.15.Immunosuppressants (Cyclosporin A, Everolimus, Mycophenolic acid, Sirolimus, Tacrolimus) |
12.1.16.Antifungals (Fluconazole, Itraconazole, Voriconazole, Posaconazole, Anidulafungin, Ketoconazole) |
12.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Immuno- Assay, |
12.2.2.Mass Spectrometry, |
12.2.3.GC-MS/MS, |
12.2.4.Others |
12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.ARK Diagnostics, Inc. |
13.2.2.Beckman Coulter |
13.2.3.Ortho Clinical Diagnostics |
13.2.4.Sekisui Diagnostics |
13.2.5.SJK Global, LLC |
13.2.6.Chromsystems |
13.2.7.Meridian Healthcare S.R.L. |
13.2.8.Randox Laboratories Ltd |
13.2.9.Sekisui Medical Co. Ltd. |
13.2.10.Thermo Fisher Scientific |
13.2.11.North American Science Associates, Inc. |
13.2.12.Ortho Clinical Diagnostics, Randox Laboratories Ltd |
14. Research Methodology |
15. Appendix and Abbreviations |